"I hope the new government will work hard on CL. The issue is very important for Thais," Suchart said.
Activists have hailed Thailand's drive for copycat drugs as a "beacon" for other developing nations seeking to provide treatments to the poor.
But pharmaceutical giants have derided it as an infringement on their intellectual property rights, warning that lost profits would make it harder to finance research for medical innovations.
A Bangkok office for Novartis could not be reached for comment.
Source-AFP
SRM/L